FDA Moves to Reevaluate Several Peptides American Med Spa Association BPC 157 Peptide Therapy New Results Medical Weight Loss The FDA scheduled a hearing on peptides and the implications could be significant for prescribers and Big news in the peptide world. , The FDA has scheduled a formal hearing in July to review 7 peptides including BPC 157 and TB 500 for legal compounding. , This isnt approval. But its The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with